Post-earnings recap
Reported
Thu, Feb 3, 2011
EPS actual
$0.45
EPS est.
$0.88
EPS surprise
-48.53%
1-day move
+2.79%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
GSK's earnings report shows a significant miss on EPS, indicating challenges in profitability. Despite this, the stock rose by 2.79%, which may reflect investor optimism or a reaction to other factors not detailed in the earnings report. The lack of guidance leaves uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.45 | N/A | -48.53% |
Management expressed concerns about the current performance but remains committed to their long-term vision. They did not provide specific guidance for the upcoming quarters.
Management acknowledged the challenges faced this quarter.
They emphasized a focus on long-term strategies despite the short-term results.